The latest applications of exosome-mediated drug delivery in anticancer therapies DOI

Zhiwei Wen,

Wei Zhang, Wei Wu

et al.

Colloids and Surfaces B Biointerfaces, Journal Year: 2025, Volume and Issue: 249, P. 114500 - 114500

Published: Jan. 6, 2025

Language: Английский

Unravelling exosome paradigm: Therapeutic, diagnostic and theranostics application and regulatory consideration DOI
Reetika Tandon, Nidhi Srivastava

Life Sciences, Journal Year: 2025, Volume and Issue: unknown, P. 123472 - 123472

Published: Feb. 1, 2025

Language: Английский

Citations

1

From Plant Based Therapy to Plant-Derived Vesicle-Like Nanoparticles for Cancer Treatment: Past, Present and Future DOI Creative Commons
Ye An, Jian‐Xuan Sun, Si‐Yang Ma

et al.

International Journal of Nanomedicine, Journal Year: 2025, Volume and Issue: Volume 20, P. 3471 - 3491

Published: March 1, 2025

Cancer stands as a formidable malady profoundly impacting human health. Throughout history, plant-based therapies have remained pivotal in the arsenal against cancer, evolving alongside epochs. Presently, challenges such arduous extraction of active components and potential safety concerns impede progression anticancer therapies. The isolation plant-derived vesicle-like nanoparticles (PDVLNs), kind lipid bilayer capsules isolated from plants, has brought therapy into novel realm led to decades research on PDVLNs. Accumulating evidence indicates that PDVLNs can deliver substances cells regulate cellular functions. Regulating immunity, inducing cell cycle arrest, promoting apoptosis cancer are most commonly reported mechanisms tumor suppression. Low immunogenicity lack tumorigenicity make good platform for drug delivery. molecules within all source so selection plants is crucial. In recent years, there been clear trend changed vegetables or fruits medicinal plants. This review highlights identify candidate More importantly, current PDVLN-based applications delivery systematically discussed.

Language: Английский

Citations

1

Development of rice bran-derived nanoparticles with excellent anti-cancer activity and their application for peritoneal dissemination DOI Creative Commons
Daisuke Sasaki,

Hinako Suzuki,

Kosuke Kusamori

et al.

Journal of Nanobiotechnology, Journal Year: 2024, Volume and Issue: 22(1)

Published: March 16, 2024

Abstract Background Rice bran a by-product of the rice milling process is currently underutilized. Recent studies have shown that plant-derived nanoparticles (pdNPs) can be mass-produced at low cost and exhibit biological therapeutic activities. contains various anti-cancer compounds, including γ-oryzanol γ-tocotrienol, bran-derived (rbNPs) employed as novel agents for cancer treatment. Results Koshihikari was suspended in water, suspension centrifuged filtered through 0.45-µm-pore size syringe filter. The filtrate ultracentrifuged, precipitates were to obtain rbNPs. rbNPs negatively charged exosome-like with an average diameter approximately 130 nm. exhibited cytotoxic activities against cells but not normal cells. activity murine colon adenocarcinoma colon26 significantly greater than DOXIL ® or other pdNPs. induced cell cycle arrest apoptosis, reduced expression proliferative proteins, β-catenin cyclin D1. Intraperitoneal injections into mice bearing peritoneal dissemination suppressed tumor growth no significant adverse effects. Conclusion These results indicated are promising nanoparticles, hold potential applications, expected play vital role

Language: Английский

Citations

8

Plant-Derived Extracellular Vesicles: Natural Nanocarriers for Biotechnological Drugs DOI Open Access
Eleonora Calzoni, Agnese Bertoldi, Gaia Cusumano

et al.

Processes, Journal Year: 2024, Volume and Issue: 12(12), P. 2938 - 2938

Published: Dec. 23, 2024

Plant-derived extracellular vesicles (PDEVs) are lipid bilayer nanoparticles, naturally produced by plant cells, with sizes ranging from 50 to 500 nm. Recent studies have highlighted their great potential in the biotechnological and medical fields, due natural origin, high biocompatibility intrinsic therapeutic properties. PDEVs contain a complex biological cargo of proteins, lipids, nucleic acids secondary metabolites, including antioxidants anti-inflammatory molecules, making them ideal for biomedical applications such as drug delivery. These play key role intercellular communication gene regulation, proving be particularly promising personalized medicine. ability improve stability bioavailability, optimizing targeted release minimizing side effects. Despite some challenges, compositional variability need standardized protocols, at gunsight innovative research aimed improving loading capacity specificity. This review aims provide comprehensive overview PDEVs, exploring structure, isolation methods, functional characteristics, applications, highlighting advantages over synthetic nanoparticles animal-derived vesicles, leading an sustainable solution development new approaches.

Language: Английский

Citations

7

Plant-derived nanovesicles: harnessing nature's power for tissue protection and repair DOI Creative Commons

Xiaohang Chen,

Xiaojie Xing,

Shuoqi Lin

et al.

Journal of Nanobiotechnology, Journal Year: 2023, Volume and Issue: 21(1)

Published: Nov. 24, 2023

Abstract Tissue damage and aging lead to dysfunction, disfigurement, trauma, posing significant global challenges. Creating a regenerative microenvironment resist external stimuli induce stem cell differentiation is essential. Plant-derived nanovesicles (PDNVs) are naturally bioactive lipid bilayer that contain proteins, lipids, ribonucleic acid, metabolites. They have shown potential in promoting growth, migration, into various types of tissues. With immunomodulatory, microbiota regulatory, antioxidant, anti-aging bioactivities, PDNVs valuable resisting facilitating tissue repair. The unique structure provides an optimal platform for drug encapsulation, surface modifications enhance their stability specificity. Moreover, by employing synergistic administration strategies, can maximize therapeutic potential. This review summarized the progress prospects as tools, provided insights selection repair activities based on existing studies, considered key challenge clinical application, anticipated continued prominent role field biomedicine. Graphical

Language: Английский

Citations

17

Plant-Derived Vesicles: A New Era for Anti-Cancer Drug Delivery and Cancer Treatment DOI Creative Commons
Yuying Zhao, Hanxu Tan,

Juping Zhang

et al.

International Journal of Nanomedicine, Journal Year: 2023, Volume and Issue: Volume 18, P. 6847 - 6868

Published: Nov. 1, 2023

Abstract: Lipid-structured vesicles have been applied for drug delivery system over 50 years. Based on their origin, lipid-structured are divided into two main categories, namely synthetic lipid (SLNVEs) and of mammalian origin (MDVEs). Although SLNVEs can stably transport anti-cancer drugs, biocompatibility is poor degradation exogenous substances a potential risk. Unlike SLNVEs, MDVEs excellent but limited by lack stability risk contamination dangerous pathogens from donor cells. Since the first discovery plant-derived (PDVEs) in carrot cell supernatants 1967, emerging evidence has shown that PDVEs integrate advantages both MDVEs. Notably, 55 years dedicated research indicated an ideal candidate vesicle preparation, transport, disease treatment. The current review systematically focuses role cancer therapy particular compares properties with those conventional vesicles, summarizes preparation methods quality control PDVEs, discusses application delivering drugs underlying molecular mechanisms therapy. Finally, challenges future perspectives development novel therapeutic strategies against discussed. Keywords: therapy, delivery, liposome nanoparticles, mammalian-derived exosomes

Language: Английский

Citations

16

A Systematic Review on Plant-Derived Extracellular Vesicles as Drug Delivery Systems DOI Open Access

Balázs Kürtösi,

Adrienn Kazsoki, Romána Zelkó

et al.

International Journal of Molecular Sciences, Journal Year: 2024, Volume and Issue: 25(14), P. 7559 - 7559

Published: July 10, 2024

This systematic review offers a comprehensive analysis of plant-derived extracellular vesicles (PDEVs) as emerging drug delivery systems, focusing on original research articles published between 2016 and 2024 that exclusively examine the use PDEVs for delivery. After rigorous search across multiple databases, 20 relevant studies out 805 initial results were selected analysis. systematically summarizes critical data PDEV components, isolation methods, drug-loading techniques. It highlights potential to significantly enhance safety efficacy, reduce dosage toxicity, align development with sustainable environmentally friendly biotechnological processes. also emphasizes advantages over mammalian-derived vesicles, such cost-effectiveness, higher yield, reduced immunogenicity. Additionally, it explores synergistic encapsulated drugs bioactive compounds naturally present in PDEVs. study acknowledges challenges standardizing formulation methods clinical use. Overall, this provides valuable insights into current state future directions PDEV-based highlighting their promising role advancing pharmaceutical development.

Language: Английский

Citations

6

Liver cirrhosis: molecular mechanisms and therapeutic interventions DOI Creative Commons
Zihe Dong, Yeying Wang, Weilin Jin

et al.

MedComm, Journal Year: 2024, Volume and Issue: 5(10)

Published: Sept. 17, 2024

Liver cirrhosis is the end-stage of chronic liver disease, characterized by inflammation, necrosis, advanced fibrosis, and regenerative nodule formation. Long-term inflammation can cause continuous damage to tissues hepatocytes, along with increased vascular tone portal hypertension. Among them, fibrosis necessary stage essential feature cirrhosis, effective antifibrosis strategies are commonly considered key treating cirrhosis. Although different therapeutic aimed at reversing or preventing have been developed, effects not be more satisfactory. In this review, we discussed abnormal changes in microenvironment that contribute progression highlighted importance recent strategies, including lifestyle improvement, small molecular agents, traditional Chinese medicine, stem cells, extracellular vesicles, gut remediation, regulate Meanwhile, for nanoparticles discussed, as their possible underlying broad application prospects ameliorating Finally, also reviewed major challenges opportunities nanomedicine‒biological environment interactions. We hope review will provide insights into pathogenesis mechanisms thus facilitating new methods, drug discovery, better treatment

Language: Английский

Citations

6

Plant-Derived Extracellular Vesicles as a Promising Anti-Tumor Approach: A Comprehensive Assessment of Effectiveness, Safety, and Mechanisms DOI
Qiang Wei, Jing Li,

Rui Ruan

et al.

Phytomedicine, Journal Year: 2024, Volume and Issue: 130, P. 155750 - 155750

Published: May 19, 2024

Language: Английский

Citations

5

Antitumor mechanism of cannabidiol hidden behind cancer hallmarks DOI

Chaobiao Yan,

Li Yu, Hanqing Liu

et al.

Biochimica et Biophysica Acta (BBA) - Reviews on Cancer, Journal Year: 2023, Volume and Issue: 1878(4), P. 188905 - 188905

Published: May 8, 2023

Language: Английский

Citations

13